Image may be NSFW.
Clik here to view.
Clik here to view.
Janney starts Harvard Bioscience at buy
Janney Capital Markets has initiated coverage of Harvard Bioscience (NASDAQ:HBIO) with a “buy” rating and $9 fair value estimate. The stock closed at $3.72 on Wednesday. “The company has undergone a...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Harvard Apparatus to file IND for regenerated trachea trial
Harvard Apparatus Regenerative Technology (NASDAQ:HART) plans to file an IND later this year for a pivotal trial of the world’s first regenerated trachea transplant in patients facing life-threatening...
View Article
